https://www.hcplive.com/view/anti-tnf-withdrawal-leads-high-relapse-rate-ibd-patients
Mesalamine use was linked to fewer relapses in the ulcerative colitis or IBD-unclassified cohorts compared to patients with Crohn’s disease.
Create an account or login to join the discussion